MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

11.88 0.18 −1.49%
Market cap
$134.8M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(12.42%) (9.80%) (9.13%) 0.12%

+8 more TTM periods

Piotroski F-Score
4 4 4 5
ROA
(9.67%) (7.53%) (7.02%) 0.09%
ROIC
(45.91%) (35.34%) (28.07%) (8.65%)
Return on Tangible Assets
(13.59%) (10.53%) (9.83%) 0.13%
Average Days of Receivables
6.06 5.61 4.84 0.00
Free Cash Flow per Share
0.69 0.20 0.11 0.06
Free Cash Flow
7.65 2.17 1.25 0.65
Capital Expenditures
(1.14) (1.55) (5.61) (6.55)
Other line items
Cash ROIC
2.09% 0.59% 0.34% 0.17%
Accounts Receivable Turnover
118.57 117.32 133.88 0.00
Accounts Payable Turnover
2.54 2.30 2.33 2.20
Inventory Turnover
3.79 3.40 3.53 3.74
Average Days of Payables
136.31 135.06 126.59 127.11
Days of Inventory on Hand
79.31 75.55 66.76 71.52
Tax Rate
0.83 1.47 2.31 (0.88)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
75.40% 74.82% 75.02% 73.77%
Share Based Compensation of Revenue
2.14% 2.20% 1.98% 1.77%
Operating CF/Net income
(0.34) (0.19) (0.37) 29.13
Depreciation/Fixed assets
0.47 0.47 0.43 0.40
Capex/Depreciation
(0.09) (0.11) (0.41) (0.49)
Revenue per Share
28.46 31.45 35.13 39.10
Operating CF per Share
0.79 0.34 0.63 0.65
Capex per Share
(0.10) (0.14) (0.51) (0.60)
Capex to Sales
0.00 0.00 0.01 0.02

Fold the line items

Columns are period end dates